Department of Biochemistry and Molecular Pharmacology, Mario Negri Institute for Pharmacological Research, Milano 20156, Italy.
Sensors (Basel). 2012 Nov 27;12(12):16420-32. doi: 10.3390/s121216420.
Great interest is currently being devoted to the development of nanoparticles (NPs) for biomedical purposes, designed to improve the pharmacokinetic profile of their cargos (either imaging probes or drugs) and to enhance the specific targeting at the disease site. Recent works suggest that Surface Plasmon Resonance (SPR), widely used for the analysis of biomolecular interactions, represents a technique of choice for rapid and quantitative analyses of the interaction between NPs--functionalized with specific ligands--and their putative biological targets. Moreover, SPR can provide important details on the formation and the role of the protein "corona", i.e., the protein layer which coats NPs once they come into contact with biological fluids. These novel applications of SPR sensors may be very useful to characterize, screen and develop nanodevices for biomedical purposes.
目前,人们对纳米粒子(NPs)的生物医学应用开发产生了极大的兴趣,旨在改善其载体(成像探针或药物)的药代动力学特性,并增强对疾病部位的靶向特异性。最近的研究表明,表面等离子体共振(SPR)广泛用于生物分子相互作用的分析,是快速定量分析与特定配体功能化的 NPs 及其潜在生物靶标之间相互作用的首选技术。此外,SPR 还可以提供有关蛋白质“冠层”(即纳米颗粒一旦与生物流体接触就会覆盖的蛋白质层)形成和作用的重要细节。SPR 传感器的这些新应用可能非常有助于生物医学纳米器件的特性描述、筛选和开发。